Spectrum Cannabis (Spectrum), which is a subsidiary of Canopy Growth Corporation (NYSE: CGC) announced on June 18th the company’s release and introduction of a cannabis softgel product line in Canada. The cannabis softgels are Spectrum’s answer for a convenient and reliable dosing product for medical cannabis patients.

The range of softgels available for medicinal cannabis patients are different combination ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD).

All the softgels are manufactured under strict standards in Smiths Falls GMP-1 certified production campus.

The company is also dedicated to ensuring that these cannabis softgels will be always in stock and their supply will not be inadequately met to the amount of demand.

Leave a Reply